Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?
The TWEAK/Fn 14 pathway is now well known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...
Main Authors: | Daniel eBertin, Delphine eStephan, Michel eKhrestchatisky, Sophie eDesplat-Jégo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00489/full |
Similar Items
-
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
by: Adil Maarouf, et al.
Published: (2019-02-01) -
TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells
by: Delphine Stephan, et al.
Published: (2022-09-01) -
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier
by: Stephan Delphine, et al.
Published: (2013-01-01) -
TWEAK progress in dermatology: A review
by: Pramisha Kharel, et al.
Published: (2023-01-01) -
Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: An exploratory study
by: Fabiola Reyes-Martínez, et al.
Published: (2018-03-01)